These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 15328901)

  • 21. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atypical antipsychotics for psychosis in adolescents.
    Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
    Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A review of atypical antipsychotic drugs versus conventional medication in schizophrenia.
    Luft B; Taylor D
    Expert Opin Pharmacother; 2006 Sep; 7(13):1739-48. PubMed ID: 16925501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The implications of weight changes with antipsychotic treatment.
    Sussman N
    J Clin Psychopharmacol; 2003 Jun; 23(3 Suppl 1):S21-6. PubMed ID: 12832946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms of antipsychotic-induced weight gain.
    McIntyre RS; Mancini DA; Basile VS
    J Clin Psychiatry; 2001; 62 Suppl 23():23-9. PubMed ID: 11603882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Weight gain associated with atypical and typical antipsychotics during treatment of adolescent schizophrenic psychoses: A retrospective study.
    Hrdlicka M; Zedkova I; Blatny M; Urbanek T
    Neuro Endocrinol Lett; 2009; 30(2):256-61. PubMed ID: 19675512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of antipsychotic-induced weight gain in first-episode psychosis: conclusions from a randomized, double-blind, controlled prospective study of olanzapine, risperidone, and haloperidol.
    Saddichha S; Ameen S; Akhtar S
    J Clin Psychopharmacol; 2008 Feb; 28(1):27-31. PubMed ID: 18204337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ameliorating antipsychotic-induced weight gain by betahistine: Mechanisms and clinical implications.
    Lian J; Huang XF; Pai N; Deng C
    Pharmacol Res; 2016 Apr; 106():51-63. PubMed ID: 26892184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ziprasidone: an atypical antipsychotic drug for the treatment of schizophrenia.
    Stimmel GL; Gutierrez MA; Lee V
    Clin Ther; 2002 Jan; 24(1):21-37. PubMed ID: 11833834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic clozapine treatment in female rats does not induce weight gain or metabolic abnormalities but enhances adiposity: implications for animal models of antipsychotic-induced weight gain.
    Cooper GD; Harrold JA; Halford JC; Goudie AJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):428-36. PubMed ID: 17933447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antipsychotic-induced weight gain and therapeutic response: a differential association.
    Czobor P; Volavka J; Sheitman B; Lindenmayer JP; Citrome L; McEvoy J; Cooper TB; Chakos M; Lieberman JA
    J Clin Psychopharmacol; 2002 Jun; 22(3):244-51. PubMed ID: 12006893
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The clinical implications of weight gain in schizophrenia.
    Kurzthaler I; Fleischhacker WW
    J Clin Psychiatry; 2001; 62 Suppl 7():32-7. PubMed ID: 11346194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug therapy in schizophrenia.
    Ananth J; Parameswaran S; Hara B
    Curr Pharm Des; 2004; 10(18):2205-17. PubMed ID: 15281896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antipsychotic-induced weight gain: a review of the literature.
    Allison DB; Casey DE
    J Clin Psychiatry; 2001; 62 Suppl 7():22-31. PubMed ID: 11346192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Obesity and related metabolic abnormalities during antipsychotic drug administration: mechanisms, management and research perspectives.
    Baptista T; Kin NM; Beaulieu S; de Baptista EA
    Pharmacopsychiatry; 2002 Nov; 35(6):205-19. PubMed ID: 12518268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone.
    Basson BR; Kinon BJ; Taylor CC; Szymanski KA; Gilmore JA; Tollefson GD
    J Clin Psychiatry; 2001 Apr; 62(4):231-8. PubMed ID: 11379836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Weight effects associated with antipsychotics: a comprehensive database analysis.
    Parsons B; Allison DB; Loebel A; Williams K; Giller E; Romano S; Siu C
    Schizophr Res; 2009 May; 110(1-3):103-10. PubMed ID: 19321312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antipsychotic induced weight gain in schizophrenia:mechanisms and management.
    Rege S
    Aust N Z J Psychiatry; 2008 May; 42(5):369-81. PubMed ID: 18473255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Candidate gene studies of antipsychotic drug efficacy and drug-induced weight gain.
    Malhotra AK
    Neurotox Res; 2004; 6(1):51-6. PubMed ID: 15184105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Olanzapine--high potency antipsychotic drug inducing significant weight gain: a case report].
    Marić N; Josifović-Kostić D; Vuković O; Britivić D; Jasović-Gasić M
    Srp Arh Celok Lek; 2008; 136(5-6):284-8. PubMed ID: 18792627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.